Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11:474–89.

Article  PubMed  Google Scholar 

Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Adm. 2009;22:1–18.

Google Scholar 

Unnikrishnan R, Pradeepa R, Joshi SR, Mohan V. Type 2 diabetes: demystifying the global epidemic. Diabetes. 2017;66:1432–42.

Article  CAS  PubMed  Google Scholar 

Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research–INdia DIABetes (ICMR–INDIAB) study. Diabetologia. 2011;54:3022–7.

Article  CAS  PubMed  Google Scholar 

Mohan V, Deepa M, Anjana RM, Lanthorn H, Deepa R. Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19). J Assoc Physicians India. 2008;56:152–7.

CAS  PubMed  Google Scholar 

Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery disease–The Chennai Urban Population Study (CUPS no. 15). Diabet Med J Br Diabet Assoc. 2005;22:1206–11.

Article  CAS  Google Scholar 

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:S19-40.

Article  CAS  PubMed  Google Scholar 

IDF Diabetes Atlas 2021 | IDF Diabetes Atlas. Available from: https://diabetesatlas.org/atlas/tenth-edition/

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81:492–542.

En Li Cho E, Ang CZ, Quek J, Fu CE, Lim LKE, Heng ZEQ, et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72:2138–48.

Article  PubMed  Google Scholar 

Ciardullo S, Muraca E, Perra S, Bianconi E, Zerbini F, Oltolini A, et al. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ Open Diabetes Res Care. 2020;8: e000904.

Article  PubMed  PubMed Central  Google Scholar 

Ban CR, Twigg SM. Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers. Vasc Health Risk Manag. 2008;4:575–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zeisberg M, Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol - Cell Physiol. 2013;304:C216–25.

Article  CAS  PubMed  Google Scholar 

Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, et al. Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis. J Clin Exp Hepatol. 2022;12:818–29.

Article  CAS  PubMed  Google Scholar 

Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract. 2009;84:84–91.

Article  CAS  PubMed  Google Scholar 

Sinha A, Bankura B. Prevalence of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients from the Eastern region of India. Diabetes Epidemiol Manag. 2023;12: 100161.

Article  Google Scholar 

Deb R, Goswami S, Sengupta N, Baidya A, Khare VR, Datta J, et al. Prevalence of clinically significant liver fibrosis as measured by transient elastography due to non-alcoholic fatty liver disease in Indian individuals with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2024;28:385–90.

CAS  PubMed  PubMed Central  Google Scholar 

Kubihal S, Gupta Y, Shalimar, Kandasamy D, Goyal A, Kalaivani M, et al. Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. J Diabetes Investig. 2021;12:877–85.

Article  CAS  PubMed  Google Scholar 

Panikar V, Gupta A, Nasikkar N, Joshi S, Walwalkar S, Sachdev I, et al. Prevalence and association of risk factors according to liver steatosis and fibrosis stages among nonalcoholic fatty liver disease patients with type 2 diabetes mellitus in India: a cross-sectional study. J Assoc Physicians India. 2024;72:29–33.

PubMed  Google Scholar 

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202–9.

Article  PubMed  Google Scholar 

Rinaldi L, Giorgione C, Mormone A, Esposito F, Rinaldi M, Berretta M, et al. Non-invasive measurement of hepatic fibrosis by transient elastography: a narrative review. Viruses. 2023;15:1730.

Article  PubMed  PubMed Central  Google Scholar 

Afdhal NH. Fibroscan (transient elastography) for the measurement of liver fibrosis. Gastroenterol Hepatol. 2012;8:605–7.

Google Scholar 

Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717–30.

Article  PubMed  Google Scholar 

Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36:13–20.

Article  CAS  PubMed  Google Scholar 

Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med J Br Diabet Assoc. 1998;15:539–53.

Article  CAS  Google Scholar 

Amutha A, Anjana RM, Venkatesan U, Ranjani H, Unnikrishnan R, Narayan KMV, et al. Incidence of complications in young-onset diabetes: comparing type 2 with type 1 (the young diab study). Diabetes Res Clin Pract. 2017;123:1–8.

Article  PubMed  Google Scholar 

The Asia-Pacific perspective : redefining obesity and its treatment. Available from: https://iris.who.int/handle/10665/206936

Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome—A new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23:469–80.

Article  CAS  PubMed  Google Scholar 

Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatol Baltim Md. 2006;43:1317–25.

Article  CAS  Google Scholar 

Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatol Baltim Md. 2007;45:846–54.

Article  CAS  Google Scholar 

Wai C-T, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatol Baltim Md. 2003;38:518–26.

Article  Google Scholar 

Khan DA, Fatima-Tuz-Zuhra, Khan FA, Mubarak A. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients. J Ayub Med Coll Abbottabad JAMC. 2008;20:122–6.

PubMed  Google Scholar 

Lin Z-H, Xin Y-N, Dong Q-J, Wang Q, Jiang X-J, Zhan S-H, et al. Performance of the aspartate aminotransferase–to–platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatol Baltim Md. 2011;53:726–36.

Article  Google Scholar 

Kuchay MS, Choudhary NS, Mishra SK, Bano T, Gagneja S, Mathew A, et al. Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes. JGH Open Open Access J Gastroenterol Hepatol. 2021;5:915–22.

Google Scholar 

Ramakrishnan A, Velmurugan G, Somasundaram A, Mohanraj S, Vasudevan D, Vijayaragavan P, et al. Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: a cross-sectional study. eClinicalMedicine. 2022;51: 101553.

Article  PubMed  PubMed Central  Google Scholar 

Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71:793–801.

Article  PubMed